Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I. (73/191)

Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients. (74/191)

Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I. (75/191)

Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model. (76/191)

Reference values for lysosomal enzymes activities using dried blood spots samples - a Brazilian experience. (77/191)

Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII. (78/191)

A tandem mass spectrometry triplex assay for the detection of Fabry, Pompe, and mucopolysaccharidosis-I (Hurler). (79/191)

Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. (80/191)

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10